OPTINOSE, INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/67dfc597-86f0-448c-88eb-048485fdbbf6/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $78.2M | 2024-01-01 – 2024-12-31 | evidence 0001494650-25-000064 |
| FY 2023 | $71.0M | 2023-01-01 – 2023-12-31 | evidence 0001494650-24-000018 |
| FY 2022 | $76.3M | 2022-01-01 – 2022-12-31 | evidence 0001494650-23-000020 |
| FY 2021 | $74.7M | 2021-01-01 – 2021-12-31 | evidence 0001494650-22-000019 |
| FY 2020 | $49.1M | 2020-01-01 – 2020-12-31 | evidence 0001494650-21-000010 |
| FY 2019 | $34.6M | 2019-01-01 – 2019-12-31 | evidence 0001494650-20-000020 |
| FY 2018 | $7.1M | 2018-01-01 – 2018-12-31 | evidence 0001494650-19-000020 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001494650-19-000020 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).